• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Legacy Education Inc.

    10/4/24 9:59:57 PM ET
    $LGCY
    Other Consumer Services
    Real Estate
    Get the next $LGCY alert in real time by email
    SC 13G 1 formsc13g.htm

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

    (Amendment No. )*

     

    Legacy Education Inc.

    (Name of Issuer)

     

    Common stock, par value $0.001 per share

    (Title of Class of Securities)

     

    52474R 207

    (CUSIP Number)

     

    October 4, 2024

    (Date of Event Which Requires Filing of This Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☐ Rule 13d-1(b)

    ☒ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     
     

     

    CUSIP NO. 52474R 207  

     

    1

    NAMES OF REPORTING PERSONS

     

    Robert deRose

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

    (a) ☒ (b) ☐

    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON WITH

    5

    SOLE VOTING POWER

     

    51,000 (1)

    6

    SHARED VOTING POWER

     

    1,176,344 (2)

    7

    SOLE DISPOSITIVE POWER

     

    51,000 (1)

    8

    SHARED DISPOSITIVE POWER

     

    1,176,344 (2)

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,227,344 (1)(2)(3)

    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ☒

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    10.30% based on 11,867,162 shares of the Issuer’s common stock outstanding as of October 4, 2024

    12

    TYPE OF REPORTING PERSON

     

    IN

     

    (1) Represents (i) 1,000 shares of common stock held by the Robert deRose IRA and (ii) options to purchase up to 50,000 shares of common stock held by Robert deRose.

     

    (2) Represents (i) 1,077,974 shares of common stock held by the Robert D. deRose & Susan deRose Family Trust DTD 11/18/1986 and (ii) 98,370 shares of common stock held by the Allison M. deRose Trust DTD 5/29/1991. Robert deRose and his spouse, Susan deRose, are the Co-Trustees of the Robert D. deRose & Susan deRose Family Trust DTD 11/18/1986 and the Allison M. deRose Trust DTD 5/29/1991.

     

    (3) Excludes 1,000 shares of common stock held by the Susan deRose – IRA BDA. Robert deRose disclaims beneficial ownership in the securities held by the Susan deRose - IRA BDA except to the extent of any pecuniary interest therein.

     

    -2-
     

     

    CUSIP NO. 52474R 207  

     

    1

    NAMES OF REPORTING PERSONS

     

    Susan deRose

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

    (a) ☒ (b) ☐

    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON WITH

    5

    SOLE VOTING POWER

     

    1,000 (1)

    6

    SHARED VOTING POWER

     

    1,176,344 (2)

    7

    SOLE DISPOSITIVE POWER

     

    1,000 (1)

    8

    SHARED DISPOSITIVE POWER

     

    1,176,344 (2)

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,177,344 (1)(2)(3)

    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ☒

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    9.92% based on 11,867,162 shares of the Issuer’s common stock outstanding as of October 4, 2024

    12

    TYPE OF REPORTING PERSON

     

    IN

     

    (1) Represents 1,000 shares of common stock held by the Susan deRose – IRA BDA.

     

    (2) Represents (i) 1,077,974 shares of common stock held by the Robert D. deRose & Susan deRose Family Trust DTD 11/18/1986 and (ii) 98,370 shares of common stock held by the Allison M. deRose Trust DTD 5/29/1991. Susan deRose and her spouse, Robert deRose, are the Co-Trustees of the Robert D. deRose & Susan deRose Family Trust DTD 11/18/1986 and the Allison M. deRose Trust DTD 5/29/1991.

     

    (3) Excludes (i) 1,000 shares of common stock held by the Robert deRose IRA and (ii) options to purchase up to 50,000 shares of common stock held by Robert deRose. Susan deRose disclaims beneficial ownership in the securities held by Robert deRose and the Robert deRose IRA except to the extent of any pecuniary interest therein.

     

    -3-
     

     

    CUSIP NO. 52474R 207  

     

    1

    NAMES OF REPORTING PERSONS

     

    Robert D. deRose & Susan deRose Family Trust DTD 11/18/1986

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

    (a) ☒ (b) ☐

    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    California

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON WITH

    5

    SOLE VOTING POWER

    0

     

    6

    SHARED VOTING POWER

     

    1,077,974 (1)

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    1,077,974 (1)

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,077,974 (1)

    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ☐

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    9.08% based on 11,867,162 shares of the Issuer’s common stock outstanding as of October 4, 2024

    12

    TYPE OF REPORTING PERSON

     

    OO

     

    (1) Susan deRose and her spouse, Robert deRose, are the Co-Trustees of the Robert D. deRose & Susan deRose Family Trust DTD 11/18/1986.

     

    -4-
     

     

    CUSIP NO. 52474R 207  

     

    1

    NAMES OF REPORTING PERSONS

     

    Allison M. deRose Trust DTD 5/29/1991

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

    (a) ☒ (b) ☐

    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    California

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    98,370 (1)

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    98,370 (1)

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    98,370 (1)

    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ☐

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.83% based on 11,867,162 shares of the Issuer’s common stock outstanding as of October 4, 2024

    12

    TYPE OF REPORTING PERSON

     

    OO

     

    (1) Susan deRose and her spouse, Robert deRose, are the Co-Trustees of the Allison M. deRose Trust DTD 5/29/1991.

     

    -5-
     

     

    CUSIP NO. 52474R 207  

     

    1

    NAMES OF REPORTING PERSONS

     

    Robert deRose IRA

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

    (a) ☒ (b) ☐

    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    California

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    1,000 (1)

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    1,000 (1)

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,000 (1)

    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ☐

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.01% based on 11,867,162 shares of the Issuer’s common stock outstanding as of October 4, 2024

    12

    TYPE OF REPORTING PERSON

     

    OO

     

    (1) Susan deRose disclaims beneficial ownership in the securities held by the Robert deRose IRA except to the extent of any pecuniary interest therein.

     

    -6-
     

     

    CUSIP NO. 52474R 207  

     

    1

    NAMES OF REPORTING PERSONS

     

    Susan deRose - IRA BDA

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

    (a) ☒ (b) ☐

    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    California

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    1,000 (1)

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    1,000 (1)

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,000 (1)

    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ☐

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.01% based on 11,867,162 shares of the Issuer’s common stock outstanding as of October 4, 2024

    12

    TYPE OF REPORTING PERSON

     

    OO

     

    (1) Robert deRose disclaims beneficial ownership in the securities held by the Susan deRose - IRA BDA except to the extent of any pecuniary interest therein.

     

    -7-
     

     

    Item 1(a). Name of Issuer.

     

    Legacy Education Inc, a Nevada corporation (the “Issuer”).

     

    Item 1(b). Address of Issuer’s Principal Executive Offices.

     

    The principal executive office of the Issuer is located at 701 W Avenue K, Suite 123, Lancaster, CA 93534.

     

    Item 2(a). Name of Person Filing.

     

    This statement is filed on behalf of Robert deRose, Susan deRose, Robert D. deRose & Susan deRose Family Trust DTD 11/18/1986, Allison M. deRose Trust DTD 5/29/1991, Robert deRose IRA, and Susan deRose - IRA BDA. Each of the foregoing is referred to as a “Reporting Person” and collectively as the “Reporting Persons.”

     

    Item 2(b). Address of Principal Business Office or, if None, Residence.

     

    The principal business address of each Reporting Person is P.O. Box 8167, Rancho Santa Fe, CA 92067.

     

    Item 2(c). Citizenship.

     

    Each of Robert deRose and Susan deRose are citizens of the United States. Each of Robert D. deRose & Susan deRose Family Trust DTD 11/18/1986, Allison M. deRose Trust DTD 5/29/1991, Robert deRose IRA and Susan deRose - IRA BDA was formed in the state of California.

     

    Item 2(d). Title of Class of Securities.

     

    Common stock, par value $0.001 per share.

     

    Item 2(e). CUSIP Number.

     

    52474R 207

     

    -8-
     

     

    Item 3. If This Statement is Filed Pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a:

     

    Not applicable.

     

      (a) Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);
         
      (b) Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);
         
      (c) Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);
         
      (d) Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
         
      (e) An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
         
      (f) An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
         
      (g) A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
         
      (h) A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
         
      (i) A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
         
      (j) A non-U.S. institution, in accordance with § 240.13d-1(b)(1)(ii)(J);
         
      (k) Group, in accordance with § 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

     

    Item 4. Ownership.

     

    (a) Amount beneficially owned: 1,228,344 (1)(4)

     

    (b) Percent of class: 10.31% based on 11,867,162 shares of the Issuer’s common stock outstanding as of October 4, 2024

     

    (c) Number of shares as to which the person has:

     

    (i) Sole power to vote or to direct the vote: (2)(4)

    (ii) Shared power to vote or to direct the vote: (3)(4)

    (iii) Sole power to dispose or to direct the disposition of: (2)(4)

    (iv) Shared power to dispose or to direct the disposition of: (3)(4)

     

    (1) Represents (i) 1,000 shares of common stock held by the Robert deRose IRA, (ii) 1,077,974 shares of common stock held by the Robert D. deRose & Susan deRose Family Trust DTD 11/18/1986, (iii) 98,370 shares of common stock held by the Allison M. deRose Trust DTD 5/29/1991, (iv) 1,000 shares of common stock held by the Susan deRose – IRA BDA and (v) options to purchase up to 50,000 shares of common stock held by Robert deRose. Robert deRose and his spouse, Susan deRose, are the Co-Trustees of the Robert D. deRose & Susan deRose Family Trust DTD 11/18/1986 and the Allison M. deRose Trust DTD 5/29/1991.

     

    -9-
     

     

    (2) Robert deRose has the sole power to vote or to direct the vote and power to dispose or to direct the disposition of 51,000 shares of common stock which represents (i) options to purchase up to 50,000 shares of common stock held by Robert deRose and (ii) 1,000 shares of common stock held by the Robert deRose IRA. Susan deRose has the sole power to vote or to direct the vote and power to dispose or to direct the disposition of 1,000 shares of common stock held by the Susan deRose – IRA BDA. Each of Robert D. deRose & Susan deRose Family Trust DTD 11/18/1986, Allison M. deRose Trust DTD 5/29/1991, Robert deRose IRA, and Susan deRose – IRA BDA have the sole power to vote or to direct the vote and power to dispose or to direct the disposition of 0 shares of common stock.

     

    (3) Each of Robert deRose and Susan deRose have the shared power to vote or to direct the vote and power to dispose or to direct the disposition of 1,176,344 shares of common stock which represents (i) 1,077,974 shares of common stock held by the Robert D. deRose & Susan deRose Family Trust DTD 11/18/1986 and (ii) 98,370 shares of common stock held by the Allison M. deRose Trust DTD 5/29/1991. Robert D. deRose & Susan deRose Family Trust DTD 11/18/1986 has the shared power to vote or to direct the vote and power to dispose or to direct the disposition of 1,077,974 shares of common stock. Allison M. deRose Trust DTD 5/29/1991 has the shared power to vote or to direct the vote and power to dispose or to direct the disposition of 98,370 shares of common stock. Robert deRose IRA has the shared power to vote or to direct the vote and power to dispose or to direct the disposition of 1,000 shares of common stock. Susan deRose – IRA BDA has the shared power to vote or to direct the vote and power to dispose or to direct the disposition of 1,000 shares of common stock.

     

    (4) Robert deRose disclaims beneficial ownership in the securities held by the Susan deRose - IRA BDA except to the extent of any pecuniary interest therein. Susan deRose disclaims beneficial ownership in the securities held by Robert deRose and the Robert deRose IRA except to the extent of any pecuniary interest therein.

     

    Item 5. Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that as of the date hereof the Reporting Person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [    ].

     

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.

     

    Not Applicable.

     

    -10-
     

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

     

    Not Applicable.

     

    Item 8. Identification and Classification of Members of the Group.

     

    See Exhibit 99.1.

     

    Item 9. Notice of Dissolution of Group.

     

    Not Applicable.

     

    Item 10. Certifications.

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the Issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

    -11-
     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of his knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

     

    Date: October 4, 2024  
       
    Robert deRose  
       
    /s/ Robert deRose  
       
    Susan deRose  
       
    /s/ Susan deRose  

     

    Robert D. deRose & Susan deRose Family Trust DTD 11/18/1986
         
    By: /s/ Robert deRose  
    Name: Robert deRose  
    Title: Co-Trustee  
         
    By: /s/ Susan deRose  
    Name: Susan deRose  
    Title: Co-Trustee  
         
    Allison M. deRose Trust DTD 5/29/1991  
         
    By: /s/ Robert deRose  
    Name: Robert deRose  
    Title: Co-Trustee  
         
    By: /s/ Susan deRose  
    Name: Susan deRose  
    Title: Co-Trustee  
         
    Robert deRose IRA  
         
    By: /s/ Robert deRose  
    Name: Robert deRose  
    Title: Trustee  
         
    Susan deRose – IRA BDA  
         
    By: /s/ Susan deRose  
    Name: Susan deRose  
    Title: Trustee  

     

    -12-

     

    Get the next $LGCY alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LGCY

    DatePrice TargetRatingAnalyst
    10/22/2024$8.25Outperform
    Northland Capital
    10/22/2024$8.19Buy
    Ladenburg Thalmann
    More analyst ratings

    $LGCY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Amato Gerald sold $57,462 worth of shares (6,000 units at $9.58), decreasing direct ownership by 8% to 65,000 units (SEC Form 4)

    4 - Legacy Education Inc. (0001836754) (Issuer)

    6/11/25 7:16:45 PM ET
    $LGCY
    Other Consumer Services
    Real Estate

    Director Amato Gerald sold $46,800 worth of shares (5,000 units at $9.36), decreasing direct ownership by 7% to 71,000 units (SEC Form 4)

    4 - Legacy Education Inc. (0001836754) (Issuer)

    6/9/25 4:15:49 PM ET
    $LGCY
    Other Consumer Services
    Real Estate

    Large owner Derose Robert gifted 10,000 shares (SEC Form 4)

    4 - Legacy Education Inc. (0001836754) (Issuer)

    4/10/25 4:15:19 PM ET
    $LGCY
    Other Consumer Services
    Real Estate

    $LGCY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Legacy Education Inc. Schedules Fourth Quarter and Fiscal Year-End 2025 Earnings Release and Conference Call

    LANCASTER, Calif., Sept. 19, 2025 /PRNewswire/ -- Legacy Education Inc. ("Legacy Education" or the "Company") (NYSE:LGCY), a leading provider of career education healthcare programs, announced today that it will host a conference call to discuss its fourth quarter and fiscal year-end financial results on Thursday, September 25, 2025 at 4:30 p.m. Eastern time. A news release outlining Legacy Education's results will be issued by 4:05 p.m. Eastern time on that day. To access the live webcast of the conference call, please go to the investor relations section of the Legacy Educat

    9/19/25 8:30:00 AM ET
    $LGCY
    Other Consumer Services
    Real Estate

    Legacy Education Inc. Appoints Two Distinguished Experts to Board of Directors

    LANCASTER, Calif., Sept. 16, 2025 /PRNewswire/ -- Legacy Education Inc. ("Legacy Education" or the "Company") (NYSE:LGCY), a leading provider of career education healthcare programs, announces the appointment of Zwade J. Marshall, MD, MBA and Janis L. Paulson to its Board of Directors. These individuals bring significant experience in clinical medicine, financial innovation, and higher education leadership, further strengthening Legacy's ability to expand access to high-quality healthcare training programs. Dr. Zwade J. Marshall, MD, MBADr. Marshall is the Co-Founder and Chief

    9/16/25 9:00:00 AM ET
    $LGCY
    Other Consumer Services
    Real Estate

    Legacy Education Expands Allied Health Portfolio with New Degree and Certificate Programs

    Four newly approved programs strengthen Legacy Education's role in preparing the next generation of healthcare professionals LANCASTER, Calif., Sept. 10, 2025 /PRNewswire/ -- Legacy Education Inc. ("Legacy Education" or the "Company") (NYSE American: LGCY), a leading provider of career education healthcare programs, announced today that two of its institutions, High Desert Medical College (HDMC) and Central Coast College (CCC), have been approved by the Accrediting Council for Continuing Education & Training (ACCET) to offer four new programs designed to address the rising demand for skilled healthcare professionals.

    9/10/25 9:00:00 AM ET
    $LGCY
    Other Consumer Services
    Real Estate

    $LGCY
    SEC Filings

    View All

    Legacy Education Inc. filed SEC Form 8-K: Leadership Update

    8-K - Legacy Education Inc. (0001836754) (Filer)

    9/12/25 4:30:29 PM ET
    $LGCY
    Other Consumer Services
    Real Estate

    Amendment: SEC Form SCHEDULE 13G/A filed by Legacy Education Inc.

    SCHEDULE 13G/A - Legacy Education Inc. (0001836754) (Subject)

    7/22/25 1:20:37 PM ET
    $LGCY
    Other Consumer Services
    Real Estate

    SEC Form 144 filed by Legacy Education Inc.

    144 - Legacy Education Inc. (0001836754) (Subject)

    6/5/25 4:17:17 PM ET
    $LGCY
    Other Consumer Services
    Real Estate

    $LGCY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Northland Capital initiated coverage on Legacy Reserves with a new price target

    Northland Capital initiated coverage of Legacy Reserves with a rating of Outperform and set a new price target of $8.25

    10/22/24 8:56:52 AM ET
    $LGCY
    Other Consumer Services
    Real Estate

    Ladenburg Thalmann initiated coverage on Legacy Reserves with a new price target

    Ladenburg Thalmann initiated coverage of Legacy Reserves with a rating of Buy and set a new price target of $8.20

    10/22/24 6:49:52 AM ET
    $LGCY
    Other Consumer Services
    Real Estate

    $LGCY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Derose Robert bought $19,994 worth of shares (3,000 units at $6.66) (SEC Form 4)

    4 - Legacy Education Inc. (0001836754) (Issuer)

    3/14/25 4:07:46 PM ET
    $LGCY
    Other Consumer Services
    Real Estate

    Large owner Derose Robert bought $16,580 worth of shares (2,000 units at $8.29) (SEC Form 4)

    4 - Legacy Education Inc. (0001836754) (Issuer)

    2/18/25 9:54:28 PM ET
    $LGCY
    Other Consumer Services
    Real Estate

    Large owner Derose Robert bought $22,650 worth of shares (3,000 units at $7.55) (SEC Form 4)

    4 - Legacy Education Inc. (0001836754) (Issuer)

    1/15/25 6:02:16 AM ET
    $LGCY
    Other Consumer Services
    Real Estate

    $LGCY
    Financials

    Live finance-specific insights

    View All

    Legacy Education Inc. Schedules Fourth Quarter and Fiscal Year-End 2025 Earnings Release and Conference Call

    LANCASTER, Calif., Sept. 19, 2025 /PRNewswire/ -- Legacy Education Inc. ("Legacy Education" or the "Company") (NYSE:LGCY), a leading provider of career education healthcare programs, announced today that it will host a conference call to discuss its fourth quarter and fiscal year-end financial results on Thursday, September 25, 2025 at 4:30 p.m. Eastern time. A news release outlining Legacy Education's results will be issued by 4:05 p.m. Eastern time on that day. To access the live webcast of the conference call, please go to the investor relations section of the Legacy Educat

    9/19/25 8:30:00 AM ET
    $LGCY
    Other Consumer Services
    Real Estate

    LEGACY EDUCATION INC. ACHIEVES RECORD Q3 WITH 50% REVENUE GROWTH AND SURPASSES 3,000 ENROLLED STUDENTS

    LANCASTER, Calif., May 15, 2025 /PRNewswire/ -- Legacy Education Inc. (NYSE:LGCY), a leading provider of career-focused education and training, today announced financial and operating results for the third fiscal quarter ended March 31, 2025. Legacy Education Inc. will host a conference call to discuss third quarter financial results today, Thursday, May 15, 2025, at 4:30 p.m. Eastern time. Toll-free dial-in number is (877) 407-9785 and international dial-in number is (201) 689-8843. To access the live webcast of the conference call, please go to the investor relations section

    5/15/25 4:05:00 PM ET
    $LGCY
    Other Consumer Services
    Real Estate

    Legacy Education Inc. Schedules Third Quarter Fiscal Year 2025 Earnings Release and Conference Call

    LANCASTER, Calif., May 1, 2025 /PRNewswire/ -- Legacy Education Inc. ("Legacy Education" or the "Company") (NYSE:LGCY) announces that it will host a conference call to discuss its third quarter financial results on Thursday, May 15, 2025 at 4:30 p.m. Eastern time. A news release outlining Legacy Education's results will be issued by 4:05 p.m. Eastern time on that day. To access the live webcast of the conference call, please go to the investor relations section of the Legacy Education website at www.legacyed.com. Participants may also register via teleconference at Q3 FY 2025

    5/1/25 9:00:00 AM ET
    $LGCY
    Other Consumer Services
    Real Estate

    $LGCY
    Leadership Updates

    Live Leadership Updates

    View All

    Legacy Education Inc. Appoints Two Distinguished Experts to Board of Directors

    LANCASTER, Calif., Sept. 16, 2025 /PRNewswire/ -- Legacy Education Inc. ("Legacy Education" or the "Company") (NYSE:LGCY), a leading provider of career education healthcare programs, announces the appointment of Zwade J. Marshall, MD, MBA and Janis L. Paulson to its Board of Directors. These individuals bring significant experience in clinical medicine, financial innovation, and higher education leadership, further strengthening Legacy's ability to expand access to high-quality healthcare training programs. Dr. Zwade J. Marshall, MD, MBADr. Marshall is the Co-Founder and Chief

    9/16/25 9:00:00 AM ET
    $LGCY
    Other Consumer Services
    Real Estate

    $LGCY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Legacy Education Inc.

    SC 13G - Legacy Education Inc. (0001836754) (Subject)

    10/4/24 9:59:57 PM ET
    $LGCY
    Other Consumer Services
    Real Estate

    SEC Form SC 13D filed by Legacy Education Inc.

    SC 13D - Legacy Education Inc. (0001836754) (Subject)

    10/3/24 4:15:30 PM ET
    $LGCY
    Other Consumer Services
    Real Estate